vs
BridgeBio Pharma, Inc.（BBIO）与RESOURCES CONNECTION, INC.（RGP）财务数据对比。点击上方公司名可切换其他公司
BridgeBio Pharma, Inc.的季度营收约是RESOURCES CONNECTION, INC.的1.3倍（$154.2M vs $117.7M），RESOURCES CONNECTION, INC.净利率更高（-10.8% vs -126.2%，领先115.5%），BridgeBio Pharma, Inc.同比增速更快（2521.2% vs -19.2%），RESOURCES CONNECTION, INC.自由现金流更多（$15.6M vs $-56.5M）
本文提供的介绍实际对应 Brent Saunders 的个人履历，而非BridgeBio Pharma, Inc. 的企业信息。Brent Saunders是美国生物制药行业高管与企业家，目前担任博士伦公司董事长兼首席执行官，曾主导参与多起大型医药并购交易，同时涉足特殊目的收购公司领域，在医疗板块拥有丰富行业经验。
RGP原名 Resources Global Professionals，是 Resources Connection, Inc. 的核心运营主体，面向全球客户提供多领域专业咨询服务，覆盖财务会计、信息管理、治理风险合规、人力资本、法务监管、企业咨询与重组、战略传播以及供应链管理等板块。
BBIO vs RGP — 直观对比
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $154.2M | $117.7M |
| 净利润 | $-194.6M | $-12.7M |
| 毛利率 | 94.7% | 37.1% |
| 营业利润率 | -90.5% | -10.3% |
| 净利率 | -126.2% | -10.8% |
| 营收同比 | 2521.2% | -19.2% |
| 净利润同比 | 27.2% | 81.6% |
| 每股收益（稀释后） | $-1.00 | $-0.38 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $154.2M | $117.7M | ||
| Q3 25 | $120.7M | $120.2M | ||
| Q2 25 | $110.6M | $139.3M | ||
| Q1 25 | $116.6M | $129.4M | ||
| Q4 24 | — | $145.6M | ||
| Q3 24 | — | $136.9M | ||
| Q2 24 | — | $148.2M | ||
| Q1 24 | $211.1M | $151.3M |
| Q4 25 | $-194.6M | $-12.7M | ||
| Q3 25 | $-184.9M | $-2.4M | ||
| Q2 25 | $-183.8M | $-73.3M | ||
| Q1 25 | $-169.6M | $-44.1M | ||
| Q4 24 | — | $-68.7M | ||
| Q3 24 | — | $-5.7M | ||
| Q2 24 | — | $10.5M | ||
| Q1 24 | $-36.2M | $2.5M |
| Q4 25 | 94.7% | 37.1% | ||
| Q3 25 | 94.6% | 39.5% | ||
| Q2 25 | 96.7% | 40.2% | ||
| Q1 25 | 97.7% | 35.1% | ||
| Q4 24 | — | 38.5% | ||
| Q3 24 | — | 36.5% | ||
| Q2 24 | — | 40.2% | ||
| Q1 24 | 99.7% | 37.0% |
| Q4 25 | -90.5% | -10.3% | ||
| Q3 25 | -120.3% | -1.7% | ||
| Q2 25 | -121.4% | -47.0% | ||
| Q1 25 | -89.5% | -38.4% | ||
| Q4 24 | — | -52.7% | ||
| Q3 24 | — | -3.5% | ||
| Q2 24 | — | 7.6% | ||
| Q1 24 | 0.2% | 2.8% |
| Q4 25 | -126.2% | -10.8% | ||
| Q3 25 | -153.2% | -2.0% | ||
| Q2 25 | -166.2% | -52.6% | ||
| Q1 25 | -145.4% | -34.0% | ||
| Q4 24 | — | -47.2% | ||
| Q3 24 | — | -4.2% | ||
| Q2 24 | — | 7.1% | ||
| Q1 24 | -17.1% | 1.7% |
| Q4 25 | $-1.00 | $-0.38 | ||
| Q3 25 | $-0.95 | $-0.07 | ||
| Q2 25 | $-0.95 | $-2.21 | ||
| Q1 25 | $-0.88 | $-1.34 | ||
| Q4 24 | — | $-2.08 | ||
| Q3 24 | — | $-0.17 | ||
| Q2 24 | — | $0.31 | ||
| Q1 24 | $-0.20 | $0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $570.1M | $89.8M |
| 总债务越低越好 | $2.0B | — |
| 股东权益账面价值 | $-2.1B | $194.6M |
| 总资产 | $936.0M | $289.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $570.1M | $89.8M | ||
| Q3 25 | $643.0M | $77.5M | ||
| Q2 25 | $756.9M | $86.1M | ||
| Q1 25 | $540.6M | $72.5M | ||
| Q4 24 | — | $78.2M | ||
| Q3 24 | — | $89.6M | ||
| Q2 24 | — | $108.9M | ||
| Q1 24 | $519.7M | $113.8M |
| Q4 25 | $2.0B | — | ||
| Q3 25 | $2.0B | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $-2.1B | $194.6M | ||
| Q3 25 | $-1.9B | $206.4M | ||
| Q2 25 | $-1.8B | $207.1M | ||
| Q1 25 | $-1.6B | $277.8M | ||
| Q4 24 | — | $325.7M | ||
| Q3 24 | — | $407.2M | ||
| Q2 24 | — | $418.8M | ||
| Q1 24 | $-1.0B | $414.9M |
| Q4 25 | $936.0M | $289.3M | ||
| Q3 25 | $998.3M | $287.2M | ||
| Q2 25 | $1.1B | $304.7M | ||
| Q1 25 | $881.6M | $375.6M | ||
| Q4 24 | — | $424.9M | ||
| Q3 24 | — | $512.9M | ||
| Q2 24 | — | $510.9M | ||
| Q1 24 | $849.3M | $523.2M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-56.4M | $15.9M |
| 自由现金流经营现金流 - 资本支出 | $-56.5M | $15.6M |
| 自由现金流率自由现金流/营收 | -36.6% | 13.2% |
| 资本支出强度资本支出/营收 | 0.0% | 0.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $24.3M |
8季度趋势，按日历期对齐
| Q4 25 | $-56.4M | $15.9M | ||
| Q3 25 | $-109.6M | $-7.8M | ||
| Q2 25 | $-80.7M | $16.8M | ||
| Q1 25 | $-199.2M | $659.0K | ||
| Q4 24 | — | $1.8M | ||
| Q3 24 | — | $-309.0K | ||
| Q2 24 | — | $3.2M | ||
| Q1 24 | $-219.5M | $20.5M |
| Q4 25 | $-56.5M | $15.6M | ||
| Q3 25 | $-110.0M | $-8.0M | ||
| Q2 25 | $-81.3M | $16.5M | ||
| Q1 25 | — | $238.0K | ||
| Q4 24 | — | $61.0K | ||
| Q3 24 | — | $-575.0K | ||
| Q2 24 | — | $3.0M | ||
| Q1 24 | $-220.2M | $20.4M |
| Q4 25 | -36.6% | 13.2% | ||
| Q3 25 | -91.2% | -6.6% | ||
| Q2 25 | -73.5% | 11.8% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | -0.4% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | -104.3% | 13.5% |
| Q4 25 | 0.0% | 0.3% | ||
| Q3 25 | 0.4% | 0.1% | ||
| Q2 25 | 0.5% | 0.2% | ||
| Q1 25 | 0.0% | 0.3% | ||
| Q4 24 | — | 1.2% | ||
| Q3 24 | — | 0.2% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | 0.3% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.30× | ||
| Q1 24 | — | 8.04× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BBIO
暂无分部数据
RGP
| US | $93.7M | 80% |
| Non Us | $24.0M | 20% |
